Bayer Co.Lab’s Post

Move for mental health: let’s invest!

💡 Spotlight on Today's LISA Hero: Peter Nussbaumer 💡 Peter is managing director of the translational drug discovery incubator Lead Discovery Center GmbH, the early drug discovery fund #KHAN-I and its Austrian subsidiary wings4innovation GmbH, which sources investments in Austria. 🎤 Peter, what is your role in the Life Science ecosystem? 🔊 In my functions, I have been working at the interface of academic research and industrial application in the field of #drugdiscovery for the last 15 years. My goal is to enable and support the translation of innovations from basic research into clinical application for the benefit of patients. 🎤 How do you perceive Austria as a location for life sciences? 🔊 In my opinion, Austria is a very good place for life sciences, as basic research in this field is very strong and competitive, and there are excellent founder-friendly funding opportunities for startups. However, there is room for improvement in terms of dedicated, strong venture capital support and public visibility. 🎤 What are the trends you observe in the Life Science sector in Austria? 🔊 As the current hype moves into productive application, the involvement of AI will play an important role in many aspects of life sciences; but I am convinced that it will not solve all problems in drug discovery in the foreseeable future. A continuing clear trend is precision medicine which enables better treatment options for individual patients. And there is a trend towards more translational research, bringing academic innovation to clinical application, which must be further strengthened.

3 weeks ago, #HLTHEurope showed that #Europe 🇪🇺 is truly a hub of #digitalhealth innovation. However, a common conversation topic was how to stand out & expand internationally 🌎 - particularly to US? 🤷♂️ This isn't the first time I've heard this, and it certainly won't be the last. 😅 However, a primary goal at PharmStars is to directly connect startups with global pharma companies active in the US. Hence why I'm always excited when European founders apply! 🚀 👌 If you or someone you know would like to be a part of our innovations in clinical trials #Fall2024 cohort and get connected to the likes of: Alexion Pharmaceuticals, Inc. | AstraZeneca   | Boehringer Ingelheim |  Eli Lilly and Company | Novo Nordisk | Sumitomo Pharma America, Inc. then find out more and apply here (deadline is Monday 15th July!): 👉 www.pharmstars.com 👈 You'd be joining an incredible group of #European PharmStars Alumni featuring high-growth startups from: #France 🇫🇷 - Scienta Lab #Germany 🇩🇪 - OmicsChart, Orbit Health #Ireland 🇮🇪 - Akkure Genomics, Head Diagnostics, My Moves Matter #Israel 🇮🇱 - Panacea-ml #Latvia 🇱🇻 - Longenesis #Poland 🇵🇱 - Saventic Health #Portugal 🇵🇹 - Promptly Health #Spain 🇪🇸 - acceXible, MiMARK #UK 🇬🇧 - Neuroute, Samphire Neuroscience, Sano Genetics, uMed, viO HealthTech Retis, EBN - European Business & Innovation Centre Network, Enterprise Ireland, TechIreland, Netherlands Enterprise Agency , HEALTH HUB UTRECHT, Netherlands Innovation Network in Boston, Health Cluster Portugal, Business France, Wirtschaftsagentur Wien, Health Hub Vienna, LISAvienna, health innovation hub (hih), German Accelerator, EIT Health, Invest in Latvia

Why should you come to tomorrow's #synbio and #AI event beyond the speakers? Well, it's basically for the amazing connections you'll be able to make 🕸️ But before one last thing about the speakers. We've had a last-minute: Michael Chappuis, the synbio lead from AstraZeneca, will be joining the panel discussion, so that's another great reason to come! 💥 But the point of this post is to tell you about some of the attendees who’ll be there. First up, we’ll have some of the most relevant #VC in #Spain like Ysios Capital COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U. Aliath Bioventures Asabys Partners Invivo Partners (and Luis Pareras MD, PhD will be a panelist), AdBio partners or Capital Cell. So you'll get to meet some of the most active stakeholders investing in Spain's #bioeconomy 💰 But not only that, we will also have key players from both the national and international ecosystem like Biocat, BioRegion of Catalonia and Council of European BioRegions - CEBR (huge thanks to Montse Daban Marín, one of the talks I’m most excited about 💫), as well as others like EURECAT, ICEX, the Fundació Catalana per a la Recerca i la Innovació Barcelona Supercomputing Center Centro Nacional de Análisis Genómico (CNAG), and more! And hey, if networking isn’t your thing and you’re only coming for the speakers, take a look at the impressive agenda we have in the one-pager attached 👀 In the first link, you'll find the purchase link. If you're coming through us or Comunidad BioLynx, you'll get a 50% discount. Oh, and that’s another great reason to come! Where else could you meet in person such a crucial project aimed at helping more young talent thrive in Spain? The entire ATG SynBio Spain team is really excited to finally meet you in person: Daniel Jimenez Rey, Javier Salgado Aguilera Roberto Rivilla Rodriguez 💗 P.S.: By the way, huge thanks to Núria Albó Canals for sponsoring my stay in Barcelona, as usual :P

🌟 Upcoming Panel at SpinOff 2024: "INNAXE: Navigating the European Spin-off Ecosystem" 🌟 Join us for a dynamic discussion exploring the complex landscape of European spin-offs in the Life Sciences and Healthtech sectors. This panel brings together distinguished leaders who are at the forefront of innovation in their respective regions. Event Details: Date: June 21st, 2024 Time: 12:00 - 12:45 Location: Main Stage, SpinOff 2024 Panelists Include: Montse Daban Marín, PhD: As President of the Board at the Council of European BioRegions and Director at BioCat, Montse leverages her vast experience in strategic foresight and international relations to drive forward the bioregion’s agenda, promoting innovative health solutions across Europe. Hickmah Tagaully: Heading European Affairs at Medicen Paris Region, Hickmah focuses on linking biotech and medtech ecosystems across Europe, enhancing collaborative innovations that address complex health challenges. Kristina Eskenazi: Chair of the Health & Life Sciences Cluster, Kristina is instrumental in orchestrating initiatives that propel the Bulgarian life sciences sector onto the global stage, emphasizing sustainable health solutions. Karen Lindegaard: As an International Programme Manager at the Danish Life Science Cluster, Karen facilitates international cooperation, helping Danish life sciences enterprises expand their global footprint through strategic partnerships. Friedemann Loos: Representing the BioRN Life Science Cluster Rhine-Neckar, Friedemann drives the cluster’s efforts in fostering cutting-edge biotechnological research and development, making significant impacts on regional and international biotech landscapes. Alberto Baldi: As a Senior Project Manager at CEBR, Alberto is deeply involved in strengthening Europe's bioregional networks, focusing on enhancing the innovation capacity of clusters through strategic collaborations and knowledge exchange. About INNAXE: INNAXE (Inclusive and Aligned Innovation Agendas Across Europe) is a groundbreaking project led by BioCat under the Horizon Europe framework. This initiative seeks to dynamize and accelerate innovation in Life Sciences and Healthtech by fostering interconnectedness among Europe’s innovation ecosystems. Why Attend? This panel discussion is essential for anyone interested in understanding and navigating the European innovation ecosystem, particularly in the healthtech and life sciences sectors. Insights from these thought leaders will shed light on collaborative efforts and strategies that are shaping the future of healthcare and biotechnological innovations. For registration and more information, please visit www.spinoff.bg. Engage with the minds shaping the future of European innovation at SpinOff 2024! #SpinOff2024 #INNAXE4EU #HealthTech #LifeSciences #EuropeanInnovation

Exciting News! Pitching Start-ups at Global Investor Forum! 🚀   🎉 We're thrilled to announce that Sherif Idriss of Elastin Biosciences Ltd will be pitching at Global Investor Forum! 🌍✨   🚀 About Elastin Biosciences: Elastin Biosciences is a spin-off from Longaevus Technologies. They have pioneered a first-in-class Elastin-restoration platform technology, using small molecules. Using a single therapeutic and a combination-therapy approach, they have shown for the first time increased elastin expression in vivo combined with improved aortic structural integrity and function. Their technology has huge implications for elastin-deficiency diseases, as well as a huge potential for a wide range of applications.   🔍 Read more about Elastin Bioscience & Sherif Idriss: https://lnkd.in/ePYe8pdy   👏 Join us: Are you a start-up wanting to pitch your company for investors and other key players in the industry? Or are you an investor looking to meet innovative companies? Join us at I4H Global Investor Forum.   Save the date 🗓️ 27 March 2024 📍Loyens & Loeff office Rotterdam 🔗https://lnkd.in/eGyCCcH

🚀 OniX OnPoint Issue #9 is Now Live! 🚀 In this edition, we spotlight the latest advancements in biotech innovation, from cancer therapies to AI-driven drug discovery and emerging startups. We also cover venture capital trends, sponsored projects, and opportunities for partnerships and licensing. Plus, get insights on the latest FDA approvals and how they are shaping the future of healthcare! Stay ahead of the curve! 🔗 Read more here: https://lnkd.in/edUVWht9 #biotech #innovation #venturecapital #startups #technologytransfer #drugdiscovery #FDAapprovals #OniXOnPoint

Only 3 weeks until the 24th BioEquity Europe in San Sebastian, Spain. Please register now -- before it sells out! Partnering is open, 130+ biotechs confirmed to present, only a few slots left on our pre-event networking excursions (first-come, first-served). ✅ Register: https://lnkd.in/gSxxhu7 ✳️ One area to highlight -> This year's agenda focuses on: How can #biotechs "rise above the noise" to attract the right investors, partners and talent? Recent additions to the faculty, include: ➢ Arjen Lemmen of argenx ➢ Arno de Wilde of EQT Group ➢ Caroline Gaynor of Lightstone Ventures ➢ Christina Takke of V-Bio Ventures ➢ Claire Brown of Oxford Science Enterprises ➢ Dmitry 'Dima' Kuzmin of 4BIO Capital ➢ Elise Peters of Syncona Limited ➢ Florent Gros of Earlybird Venture Capital ➢ Franck Le Deu of McKinsey & Company ➢ Frank Kalkbrenner of Boehringer Ingelheim ➢ Jason P. Hafler of Sanofi ➢ Joep Muijrers of Gilde Healthcare ➢ Jonathan Tobin of Brandon Capital ➢ Karen Wagner of Ysios Capital ➢ Ksenija Pavletic of JEITO ➢ Nerida Scott of Johnson & Johnson ➢ Nina Rawal of Trill Impact ➢ Paulo Fontoura of Roche ➢ Dr. Shanshan Xu of BioNTech SE ➢ Søren Møller of Novo Nordisk And many more... I hope you will join BioCentury and EBD Group at this destination event for #biotech CEOs and investors. No event has a larger concentration of VCs than BioEquity. Please DM me if you have any questions. See you soon in San Sebastian! #venturecapital #drugdevelopment #biopharma #BioEquityEurope

The webinar will highlight how India has built a powerful ecosystem for healthcare innovation at a global scale. If you work with #innovation, #medicaldevices, #health, #technology, you should attend this event!

Come join us for an info session and networking event for the Nucleate Global Virtual Activator (GVA) at PLNT Leiden on October 10 (5:30PM - 6:30PM)! Sign up for the event here: https://lu.ma/85my2g6k We’re recruiting participants for the Nucleate GVA program—a 6-month, equity-free incubator tailored specifically to academic founders. If you’re considering spinning out a project, this could be the perfect chance to move forward. 💡 The program offers access to top biotech mentors 👩🔬👨🔬, extensive networking opportunities, workshops, and the chance to build and strengthen your team. The program kicks off with a chance to build and strengthen your team as well! Since its launch in 2021, it has already helped create over 100+ companies 🏢, raising over $370M 💰, all without requiring founders to pay any upfront costs or give up equity. If you have developed a technology, you can apply for either our: 💊 Bio Track – for innovators in therapeutics, diagnostics, or discovery platforms. 🌿 Eco Track – focused on food & agriculture, chemicals & energy, or consumer products. Don’t have an idea yet? Apply as a  scientific, business, or clinical contributor to team up with inventors through our matching process. 🎯 Notable success stories include Invitris (Germany, eventually backed by Y Combinator) and BrewRight (a Dutch start-up and winner of this year’s Eco Track pitch). Applications for the next cohort are already open 🗓️: https://lnkd.in/d_ieyyVu 👉 Check out the one-pager information sheet here: https://lnkd.in/dcXnyevc For any questions about the event, don’t hesitate to contact: Cesare Marino and Richard Dela Rosa Daniel Lin and Regan Ellis, GVA Co-Managing Directors Cesare Marino Richard Dela Rosa Esther León Sonseca Martin Holub Onur Karakaslar Samuel Feldmann William Lake Yuri van Elsas